These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7819707)

  • 1. Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.
    Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Pados G; Mantalenakis S
    J Assist Reprod Genet; 1994 Feb; 11(2):85-91. PubMed ID: 7819707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
    Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
    J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian stimulation with buserelin/HMG/HCG: prospective randomized study of short versus long protocol.
    Tarlatzis BC; Pados G; Bontis J; Lagos S; Grimbizis G; Spanos E; Mantalenakis S
    Hum Reprod; 1993 Jun; 8(6):807-12. PubMed ID: 8345067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
    Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization.
    Urbancsek J; Witthaus E
    Fertil Steril; 1996 May; 65(5):966-71. PubMed ID: 8612858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
    Wada I; Matson PL; Troup SA; Lieberman BA
    J Assist Reprod Genet; 1995 Apr; 12(4):252-7. PubMed ID: 7580021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro fertilization for women with pure tubal occlusion: the impact of short gonadotropin-releasing hormone agonist treatment.
    Luxman D; Cohen JR; Lessing JB; Yovel I; David MP; Ami A
    Fertil Steril; 1995 Feb; 63(2):357-60. PubMed ID: 7843443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of short versus long-term leuprolide acetate--human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients.
    Check JH; Nowroozi K; Chase JS
    Hum Reprod; 1992 Jan; 7(1):31-4. PubMed ID: 1551954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program.
    Balasch J; Jové IC; Moreno V; Civico S; Puerto B; Vanrell JA
    Fertil Steril; 1992 Nov; 58(5):991-4. PubMed ID: 1426388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is long-protocol gonadotropin releasing hormone agonist administration superior to the short protocol in ovarian stimulation for in vitro fertilization?
    Tasdemir M; Tasdemir I; Kodama H; Higuchi M
    Int J Fertil Menopausal Stud; 1995; 40(1):25-8. PubMed ID: 7749431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
    El-Nemr A; Bhide M; Khalifa Y; Al-Mizyen E; Gillott C; Lower AM; Al-Shawaf T; Grudzinskas JG
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):140-5. PubMed ID: 12069736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between nafarelin and leuprolide acetate for in vitro fertilization: preliminary clinical study.
    Dantas ZN; Vicino M; Balmaceda JP; Asch RH; Stone SC
    Fertil Steril; 1994 Apr; 61(4):705-8. PubMed ID: 8150114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.